When might a positive HIV test be wrong? Are your chances of surviving cancer better in the U.S. or in England? Learn how to put aside unjustified fears and hopes and how to weigh your real risk of illness-or likelihood of recovery 44 I n a 2007 campaign advertisement, former New York City mayor Rudy Giuliani said, " I had prostate cancer, five, six years ago. My chances of surviving prostate cancer-and thank God, I was cured of it-in the United States? Eighty-two percent. My chances of surviving prostate cancer in England? Only 44 percent under socialized medicine." Giuliani used these statistics to argue that he was lucky to be living in New York and not in York. This statement was big news. As we will explain, it was also a big mistake.
Trust Your Doctor?
Medicine has held a long-standing antagonism toward statistics. For centuries, treatment was based on an ethic of personal uust as opposed to quantitative facts, which were dismissed as impersonal or irrelevant to the individual. Even today many doctors think of themselves as artists, relying more on intuition and faith in their own judgment than on numbers. For their part, many patients prefer to trust their doctors rather than even asking for data to analyze. For example, in a 2008 unpublished survey by one of us (Gigerenzer) and his colleagues, two thirds of more than 100 American economists said they had not weighed any pros and cons of getting a prostate cancer screening test but simply followed their doctor's recommendation. Individuals often shy away from statistics because they have an emotional need for certainty.
FAST FACTS
Moreover, individuals often shy away from statistics because they have an emotional need forcertainty-a concept at odds with statistical literacy, which prepares us to make decisions in the face of uncertainty [see box on opposite page]. Much of the public harbors illusory certainty about the reliability of tests such as those for cancers and HIV, suggests a survey Gigerenzer conducted in 2006.
Furthermore, statistically unsophisticated patients and their doctors tend to wildly overestimate the benefits of screening tests and are blind to their harms. For example, mammography reduces the risk of a woman in her 50s dying from breast cancer from about five to four in 1,000 over some 13 years, but 60 percent of a random sample of U.S. women believed the benefit to be 80 times as high. Americans are similarly overenthusiastic about total-body computed tomographic scans: in a random sample of 500 Americans, nearly three quarters said they would prefer a free total-body CT scan to $1,000 in cash. Yet no professional medical organization endorses such scans, and several discourage them because screening tests such as this one can result in Know Your Numbers 1 )) Statistical Illiteracy Is rooted not In Intellectual deficits but in t he doctor-patient relationship, the illusion of certainty In m edicine, and the practice of presenting health Information In opaque forms that erroneously suggest big benefits and small harms from Interventions.
2 )) Without understanding the numbers, citizens are susceptible to polit ical and commercial manipulation of their anxieties and hopes. The result can be serious damage to physical health and emot ional well-being.
important harm from a cascade of medical quandries and invasive treatments triggered by ambiguous findings.
A citizen in a modern technological society faces a bewildering array of medical decisions. Should a pregnant woman undergo prenatal screening for chromosomal anomalies at age 35? Should parents send their teenage daughters to be vaccinated against human papillomavirus, to protect them against cervical cancer, despite a few reports that the vaccine (Gardasil) could lead to paralysis? If people want to make informed decisions, they need to understand health statistics. In particular, they need to understand the difference between absolute and relative risks and how to use natural frequencies to infer the true chances of disease from a positive test result. Individuals also should know to trust mortality rates over five-year survival statistics when evaluating screening tests, which look for disease in healthy people. We deal with each of these issues in turn.
Absolute Risks
In October 1995 the U.K. Committee on Safety of Medicines warned that third-generation oral contraceptive pills increased the likelihood of potentially life-threatening blood clots in the legs or lungs twofold-that is, by 100 percent. T his information was passed on in "Dear Doctor" letters to 190,000 general practitioners, pharmacists and directors of public health and in an emergency announcement to the media. The news caused great anxiety, and women stopped taking the pill, which led to an estimated 13,000 additional abortions in the following year in England and Wales. For every additional abortion, there was also one extra birth, including some 800 more conceptions among girls younger than 16. (Ironically, abortions and pregnancies arc associated with an increased risk of thrombosis that exceeds that of the third-generation pill.) Such panic could have been avoided had the data been reported in a more straightforward manner. The evidence showed that about one in every 7,000 women who took the second-generation pill had a blood clot; this number increased to two in 7,000 among women who took third-generation pills. T hat is, the absolute risk increase was only one in 7,000 even though the relative risk increase was indeed 100 percent. Absolute risks are typically small numbers, whereas the corresponding years" are easier to imagine than the widely used "lifetime• risks. They are more informative because risks change over time, and yet such time frames are long enough to enable action. » 3 How big Is the risk? Because there are no zero risks, size is what matters. Th at number should be expressed in absolute terms-for instance, 13 out of 1,000 50-year-old female smokers die of heart disease within 10 years-or in comparative terms, rel ating the risk to other ones. For exampl e, a 50-year-old female smoker has about the same chance of dying of heart disease as of lung cancer within the next decade-and these chances are about seven times higher than her risk of perishing in a car accident. » 4 Does the risk apply to me? Find out If the risk Is based on studies of people like you-Individuals of your age or sex or with health problems similar to yours.
» 5 What are the harms of " finding out?" Screening tests may lead to false alarms, prompting unnecessary anxiety. When women participate in a 10-year program of annual mammography, every other woman without cancer can expect one or more false-positive test results. Worse, screening tests often detect abnormalities that would never cause symptoms, leading to unnecessary surgery and other invasive treatments.
relative changes tend to look big-particularly when the base rate is low.
Reporting relative risks can create unrealistic hopes as well as undue anxiety. Many patients and doctors evaluate a treatment or test more favorably if benefits are expressed in terms of relative risk reduction. In a 2007 review of experimental studies, for example, psychologist Judith Covey of the University of Durham in England found that when the benefit of a drug was presented in the form of relative risk reduction, 91 percent of Danish general practitioners would recommend it to their patients. But when given the absolute risk reduction, only 63 percent would recommend the same drug.
Information brochures, doctors, medical journals and the media continue to inform the public in terms of relative changes, in part because big numbers make better headlines and generate more attention. One leaflet even conflated the two, stating that hormone replacement therapy (HRT) "bas been proven to protect women against colorectal cancer (by up to more than 50 percent)," whereas the risk of breast cancer "may possibly increase by 0.6 percent (six in 1,000)." The data reveal that the 50 percent benefit corresponds to an absolute number that is less than six in 1,000-meaning that HRT produces more cases of cancer than it prevents. But according to a 2003 study, 60 of 80 women concluded the exact opposite from the leaflet.
Absolute risks are more informative because they take into account information about background rates. Given the absolute risks, a person can derive the relative risks-but not vice versa. After all, a relative risk reduction of 50 percent could describe either a substantial mortality reduction from 200 to 100 in 10,000 patients or a much smaller one from two to one in 10,000 patients. Randomized trials provide some of the best information in med- 
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Mortality Matters
While running for president, Giuliani claimed that health care in the U.S. was superior to that in England. He apparently used data from the year 2000, when 49 British men in every 100,000 were diagnosed with prostate cancer, of whom 28 died within five years-about 44 percent. Using a similar approach, he cited a corresponding 82 percent fiveyear survival rate in the U.S., suggesting that Amer-0 © icans with prostate cancer were twice as likely to survive as their British counterparts were. That implication, however, is false because these survival statistics largely reflect diagnostic differences between the two countries rather than better treatment and prolonged survival in the U.S.
To understand why, imagine a group of prostate cancer patients diagnosed (by their symptoms) at age 67 in the U.K., all of whom die at 70. Each survived only three years, so the five-year survival of this group is 0 percent. Now imagine that the same group is diagnosed in the U.S., where doctors detect most prostate cancer by screening for prostate-specific antigens (PSA). (The PSA test is not routinely used in Britain.) These U.S. patients are diagnosed earlier, at age 60, but they all still die at age 70. All have now survived 10 years, and thus their five-year survival rate is 100 percent. Even though the survival rate has changed dramatically, (The Authors) Magnetic resonance images such as the one above (of a healthy brain) may be used to diagnose brain cancer. Companies and organizations offer such scans as screening tool s, suggesting that peopl e need one to be sure they do not have a brain tumor. But brain cancer Is quite rare, and there Is no evidence that screen· ing is beneficial.
nothing has changed about the time of death. This example shows how setting the time of diagnosis earlier can boost survival rates (lead-time bias), even if no life is prolonged or saved [see illustration on opposite page]. Spuriously high survival rates can also result from overdiagnosis, the detection of abnormalities that are technically cancer but w ill never progress to cause symptoms in the patient's lifetime. Say 1,000 men with progressive cancer do not undergo screening. After five years 440 are still alive, which results in a survival rate of 44 percent. Meanwhile in another population of men, PSA screening detects 1,000 people with progressive cancer and 2,000 people with non progressive cancer (who by definition will not die of cancer in five years). These non progressive cases are now added to the 440 who survived progressive cancer, which inflates the survival rate to 81 percent. Although the survival rate changed dramatically, the number of people who die has not changed at all.
In the U.S., screening for prostate cancer using the PSA test in the late 1980s led to an explosion in Despite the difference in survival rates, mortality rates in the two countries are close to the same: about 26 prostate cancer deaths per 100,000 American men versus 27 per 100,000 in Britain. That fact suggests the PSA test has needlessly flagged prostate cancer in many American men, resulting in a lot of unnecessary surgery and radiation treatment, which often leads to impotence or incontinence.
Because of overdiagnosis and lead-time bias, changes in five-year survival rates have no reliable relation to changes in mortality when patterns of diagnosis differ. And yet many official agencies continue to talk about five-year survival rates. A recent report by the U.K. Office for National Statistics noted that five-year survival for colon cancer was 60 percent in the U.S. as compared with 35 percent in Britain. Experts dubbed this finding "disgraceful" and called for a doubling of government spending on cancer treatment. In fact, the mortality rate for colon cancer in Britain is about the same as that in the U.S. In an even stranger case, an ad for the prestigious University of Texas M.D. Anderson Cancer Center conflated survival rates with mortality rates: "as national mortality rates for prostate cancer fluctuated between 1960 and 1990, five-year survival rates for prostate cancer among M.D. Anderson patients continued to improve" (emphasis added).
Mortality rates arc far more reliable indicators of the value of screening programs than are fiveyear survival rates, which boost survival because of earlier diagnoses and overdiagnoses. So should a man get a PSA test or a smoker undergo a CT scan to screen for lung cancer? Both exams find more early-stage cancers-but neither has been shown to reduce mortality.
People commonly regard screening as a safeguard for their health, even if an illness is rare. But additional testing may lead to unnecessary medical interventions that can result in harm, which means there is nothing "safe" about this strategy. And for the many overdiagnosed patients, treatment can only cause harm. An epidemic of diagnoses can be as dangerous to our health as disease is. absolute risks instead of relative risks, natural frequencies instead of conditional probabilities, and mortality rates instead of five-year survival rates. In addition to changing the reporting of health statistics, we need to better educate our young people in the science of risk.
Today the U.S. mathematics curriculum centers on the mathematics of certainty-from arithmetic to calculus-and instruction in probability and statistics occurs too late. As H . G. Wells suggested, statistics should be taught as early as reading and writing. Indeed, the U.S. National Council of Teachers of Mathematics has been pushing educators for years to begin instruction in statistics and probability in primary school. If children learned to deal with an uncertain world in a playful way, much of the collective statistical illiteracy would be history.
Furthermore, teachers need to approach statistics differently. Instead of instructing students about how to apply formulas to toy problems involving cards and dice, teachers should show them how to use numbers to solve real-world predicaments. Statistics might even be wrenched away from math educators to create a problem-solving field connected to teaching health in schools. Such a new field might help young people make better decisions about drugs, alcohol use, driving, biotechnology and other relevant health issues.
In an excellent example of this approach, one secondary school textbook tells the real story of a 26-year-old single mother who tested positive in a routine HIV test, lost her job, moved into a halfway house with other HIV-positive residents, had unprotected sex with one of them, eventually devel- 
